Unlock instant, AI-driven research and patent intelligence for your innovation.

MiR-15a target site sequence and application of miR-15a target site sequence in restraining hepatitis B virus replication

A hepatitis B virus, 1.mir-15a technology, applied in the fields of molecular biology and antivirology, can solve the problems affecting the occurrence of liver cysts and other problems, and achieve the effect of inhibiting replication

Inactive Publication Date: 2015-04-22
WUHAN UNIV
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] At present, some studies have found that miR-15a plays an important role in some important cancers and diseases. For example, its expression is related to chronic B-lymphoblastic leukemia (B-CLL): the deletion of Bq14, which is common in B-CLL, can lead to miR15a and deexpression of miR16a; (Calin GA, Sevignani C, Dumitru CD, et a1. Human micreRNA genes are frequently located at fragile sites and genomic regions involved in cancers[J]. Proc Nail Acad Sci USA, 2004, 101(9) : 2999-30o4.) At the same time, it was also found that it can affect the occurrence of hepatic cysts by regulating the expression of gene Cdc25a, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • MiR-15a target site sequence and application of miR-15a target site sequence in restraining hepatitis B virus replication
  • MiR-15a target site sequence and application of miR-15a target site sequence in restraining hepatitis B virus replication
  • MiR-15a target site sequence and application of miR-15a target site sequence in restraining hepatitis B virus replication

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0062] Example 1: Effects of protein components Ago2 and Dicer in knock-down miRNA's pathway on the replication of HBV.

[0063] The siRNA for knock-down Ago2 and Dicer is as follows: (Shanghai Gemma Biotechnology Co., Ltd.)

[0064] si Ago2: 5'-GCACGGAAGUCCAUCUGAATT-3';

[0065] si Dicer: 5'-UGCUUGAAGCAGCUCUGGA-3'.

[0066] Plasmid pCH9-3091 used in the present invention (NassalM. The arginine-rich domain of the hepatitis B virus core protein is required for pre-genome encapsidation and productive viral positive strand DNA synthesis but not for virus assembly [J]. J Viro, 11992, 66(7):4107-4116.) contains the whole genome of HBV, and after the plasmid is transfected into HepG2 cells for 48 hours, HBV virus particles will be produced.

[0067] 1. Transfection of siRNA and plasmid pCH9-3091:

[0068] The following transfection operation takes a 24-well plate as an example, and the whole process of transfection must be strictly aseptic.

[0069] 1. First, mix 1ul siAgo2 or s...

Embodiment 2

[0106] Example 2: Mix chemically synthesized miR-15a mimic and miR-15a inhibitor with plasmid pCH9-3091, and transfect into HepG2 cells through lipofectamine2000 liposome reagent. After 2-3 days, pass ELISA Detection of HbsAg and HbeAg secreted by HBV.

[0107] The transfection process and conditions were the same as in Example 1. The sequence of miR-15a mimic is: 5'-uagcagcacauaauguuugug-3'; the sequence of miR-15a inhibitor is: 5'-cacaaaccauuaugugcugcua-3.

[0108] The process and conditions of RT-PCR were the same as in Example 1. Reverse transcription primers for miR-15a:

[0109] GTCGTATCCAGTGCGTGTCGTGGAGTCGGCAATTGCACTGGATACGACCACAAACC;

[0110] The quantitative primers for miR5a are: miR-15aF, TAGCAGCACATAATGGTTTGTG; miR5aR: TGCGTGTCGTGGAGTC;

[0111] The internal reference is actin, and the quantitative primers are actinF: cgtggacatccgcaaagac; actinR: tggaaggtggacagcgaggc. After the reaction, the software that comes with Rotors gene was used for data analysis.

[...

Embodiment 3

[0114] Example 3: Prediction of miR-15a has miR15a-targeted sequences in the p region of HBV.

[0115] Using the biological software Target scan (Lewis et al., 2005) to predict the target sequence of miR5a on the HBV genome, the results are as follows image 3 Shown: 4 potential target sites of miR-15a were predicted on the HBV genome using the software mentioned above, and their specific positions are as follows. There are three sites in the CDS region of HBp, and the specific positions on the HBV genome are respectively Yes: 2645-2666bp, 2677-2698bp and 2686-2707bp. The fourth site is located in the overlapping region of HBp and HBx, and the specific position on the HBV genome is 2900-2921bp. The present invention will determine this target site and prepare a mutation vector containing the target site PRL-HBX- mut, the carrier carries out corresponding base mutations at potential target sites in the HBx region, as shown by the arrows in the figure: T to G, T to C.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a miR-15a target site sequence and application of the miR-15a target site sequence in restraining hepatitis B virus replication. MiR-15a is targeted on a function site in the sequence so as to restrain replication of hepatitis B virus of people. The nucleotide sequence of the target function site is shown on SEQIDNo.1. The target site sequence provides a new medicine target and treating method for researching and developing some novel antiviral drugs for treating relevant diseases caused by HBV virus. Meanwhile, as microRNA is produced by cell expression, toxicity of the microRNA on cells is small compared with other drug which is synthesized manually but not synthesized by the cells, and an effect is good.

Description

technical field [0001] The present invention relates to the fields of molecular biology and antivirals, in particular to a miR-15a target site sequence, and the application of a miR-15a target site sequence in the preparation of drugs for inhibiting hepatitis B virus replication . According to the present invention, there is a miR-15a target site sequence on the HBV genome, and miR-15a can inhibit HBV replication by directly targeting the site. Background technique [0002] Hepatitis B virus (HBV) is a DNA virus, a circular, partially double-stranded DNA molecule consisting of about 3200 nucleotides. Its replication can cause acute and chronic hepatitis in humans, and may lead to liver cirrhosis and liver cancer. At present, about 6% of the whole world are carriers of the virus, so the persistent infection of hepatitis B virus has become a global health problem. [0003] There is currently no effective way to treat the disease caused by infection with the hepatitis B viru...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/51A61K48/00A61P1/16A61P31/20
Inventor 王艳玲杨波季雄张翼付向东
Owner WUHAN UNIV